Click here to view the CareFirst BCBS Blue Cross Blue Shield Medical Policy Updates »…
BCBS Alabama Medical Policy Updates – October 2018
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
October 2018 BCBS Alabama Medical Policy Updates:
- Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
- Addyi
- Afrezza
- Amantadine Extended Release
- Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide)
- Ampyra (dalfampridine)
- Androgens and Anabolic Steroids
- Atopic Dermatitis
- Atopic Dermatitis
- Atypical Antipsychotic Step Therapy (ST)
- BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
- Benlysta (belimumab)
- Biologic Immunomodulators
- BRAF Gene Mutation Variant Testing To Select Melanoma or Glioma Patients for Targeted Therapy
- Cardioverter Defibrillators: Wearable or External
- CGRP
- Circadian Rhythm Disorder
- Computed Tomography Perfusion Imaging of the Brain
- Computer-Assisted Navigation for Orthopedic Procedures
- Contraceptive
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- Endobronchial Ultrasound for Diagnosis and Staging of Lung Cancer
- Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
- Flector
- Foot Orthotics and Orthopedic Shoes
- Gabapentin ER (extended-release)
- Genetic Testing for Hereditary Breast/Ovarian Cancer (BRCA1 or BRCA2)
- Genetic Testing for Heterozygous Familial Hypercholesterolemia
- Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment
- Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
- Glucose Test Strips/Disks/ Meters
- Growth Hormone
- Hereditary Angioedema
- Homozygous Familial Hypercholesterolemia Agents (HoFH)
- Idiopathic Pulmonary Fibrosis
- Implantable Sinus Stents and Drug-Eluting Implants for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinus Disease
- Inhaled Antibiotics Duplicate Therapy
- Insomnia Agents
- Insulin
- Insulin Combination (Soliqua, Xultophy)
- Intraoperative Neurophysiologic Monitoring
- Keveyis
- Lower Limb Prostheses
- Lyrica (pregabalin CR)
- Magnetic Resonance Guided Focused Ultrasound (MRgFUS)
- Magnetoencephalography/Magnetic Source Imaging
- Metformin ER
- Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
- Moderate Penetrance Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk
- Multiple Sclerosis Agents
- Northera (droxidopa)
- Nutritional Treatment of Childhood Medical Conditions
- Nuvigil/armodafinil, Provigil/modafinil
- Opioid Immediate Release
- Opioids ER
- Phenylketonuria
- Prostatic Urethral Lift
- Selective Serotonin Inverse (SSIA)
- Self Administered Oncology Agents
- Statin Step Therapy
- Substrate Reduction Therapy
- Surgical Treatments for Lymphedema
- Thrombopoietin Receptor
- Topiramate ER
- Total Artificial Hearts and Implantable Ventricular Assist Devices Ventricular Assist Devices and Total Artificial Hearts
- Transmucosal Immediate Release Fentanyl (TIRF)
- Treatment of Cervicogenic Headache and Occipital Neuralgia
- Triptans
- URAT1 Inhibitor
- Vertebral Fracture Assessment with Dual X-Ray Absorptiometry (DEXA)
- Whole Body Dual X-Ray Absorptiometry (DEXA) to Determine Body Composition
- Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
- Xanthine Oxidase Inhibitor
- Xyrem (sodium oxybate)
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
